CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery [Phase 2]

A Phase 2 trial of TAK-018 in preventing Crohn's disease recurrence after surgery was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Crohn Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-09-07